Product Images Doxazosin

This is a drug called Doxazosin, available only on prescription, that comes in a package of 50 tablets. Each tablet contains doxazosi mesylate equivalent to 1 mg doazosin. It should be stored at 20°C to 25°C, with excursions permitted from 15°C to 30°C, and away from children. The usual dosage can be found on the package insert. The text includes instructions for pharmacists to dispense with patient information.*

Doxazosin Tablets, USP is for prescription only. Each tablet contains Doxazosin Mesylate corresponding to 2mg Doxazosin. The tablets come in a pack with 50 unit dose tablets. The usual dosage should be read on the package insert that accompanies the tablets. It is advised to store the medication between 3-20°C or 25°C (68-70°F) as per the USP Controlled Room Temperature. The medication should be kept out of children's reach. The manufacturer information indicates that the medication is manufactured for Aukare, located in Pulaski, TN.*

Doxazosin Tablets are a prescription medication with each tablet of 4mg containing doxazosin mesylate. The package size is 50 tablets, which are individually packaged in 5x10 unit doses. The recommended storage temperature is between 20°C to 25°C, and the normal dosage instructions are mentioned in the package insert. The medication needs to be kept out of the reach of children. The document also provides the pharmacist with instructions to add patient information while dispensing the medication.*

This is a description of a medicine called Doxazosin Tablets, USP. It comes in a container of 50 tablets, and each tablet contains doxazosin mesylate equivalent to 8mg of doxazosin. The medicine should be stored at 20°C to 25°C, with excursions permitted from 15°C to 30°C. The medication should be kept out of reach of children. The usual dosage is listed in the package insert, and it should be dispensed with patient information by a pharmacist. The medicine is manufactured by AUKARE in Pulaski, TN.*

The text is a table showing summaries of effectiveness data in placebo-controlled trials for maximum flow, symptom score, and rate. The table includes mean baseline change, mean baseline change for placebo, and Doxazosin. It also includes the AUA questionnaire and the Modified Boyarsky Questionnaire scores for Studies 1 and 3, respectively. The text provides information on the duration of the titration and fixed dose efficacy phase of each study. The quality of the text is good.*